Es probable que le diga que no coma ni tome nada después de la media noche del día anterior a su procedimiento. ❼ómo me preparo para mi procedimiento? Su proveedor de salud le dirá cómo prepararse para su procedimiento. La trombólisis puede restaurar el flujo sanguíneo y reducir el daño a zonas del cuerpo como a su cerebro, su corazón o sus pulmones. Un coágulo de sangre puede obstruir el flujo sanguíneo a ciertas partes de su cuerpo y puede llegar a ser de peligro mortal. ¿Qué necesito saber sobre la trombólisis? La trombólisis es un procedimiento para disolver con medicamento un coágulo de sangre. (Funded by the National Institutes of Health and Abbott Vascular Solutions CREST number, NCT00004732.). The rate of postprocedural ipsilateral stroke also did not differ between groups. No significant between-group differences with respect to either end point were detected when symptomatic patients and asymptomatic patients were analyzed separately.ĬONCLUSIONS: Over 10 years of follow-up, we did not find a significant difference between patients who underwent stenting and those who underwent endarterectomy with respect to the risk of periprocedural stroke, myocardial infarction, or death and subsequent ipsilateral stroke. With respect to the primary long-term end point, postprocedural ipsilateral stroke over the 10-year follow-up occurred in 6.9% (95% CI, 4.4 to 9.7) of the patients in the stenting group and in 5.6% (95% CI, 3.7 to 7.6) of those in the endarterectomy group the rates did not differ significantly between the groups (hazard ratio, 0.99 95% CI, 0.64 to 1.52). RESULTS: Among 2502 patients, there was no significant difference in the rate of the primary composite end point between the stenting group (11.8% 95% confidence interval, 9.1 to 14.8) and the endarterectomy group (9.9% 95% CI, 7.9 to 12.2) over 10 years of follow-up (hazard ratio, 1.10 95% CI, 0.83 to 1.44).
In addition to assessing the primary composite end point, we assessed the primary end point for the long-term extension study, which was ipsilateral stroke after the periprocedural period. METHODS: Among patients with carotid-artery stenosis who had been randomly assigned to stenting or endarterectomy, we evaluated outcomes every 6 months for up to 10 years at 117 centers. BACKGROUND: In the Carotid Revascularization Endarterectomy versus Stenting Trial, we found no significant difference between the stenting group and the endarterectomy group with respect to the primary composite end point of stroke, myocardial infarction, or death during the periprocedural period or any subsequent ipsilateral stroke during 4 years of follow-up.
0 kommentar(er)
